Vioxx should cast scrutiny on at least two problems inherent in the nation's system for assessing and monitoring drug safety. 
 The number of warning letters has dropped precipitously since the Bush administration took power, from 82 in 2000 to 24 in 2003. 
 The FDA could help solve these problems not only by enforcing its own rules but by requiring doctors and hospitals to report adverse events'' when patients use drugs.